{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:30:58Z","timestamp":1721867458683},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,24]]},"DOI":"10.7759\/cureus.65254","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T10:50:38Z","timestamp":1721818238000},"source":"Crossref","is-referenced-by-count":0,"title":["Pattern Visually Evoked Potentials (pVEPs) and Retinal Nerve Fiber Thickness in a Japanese Girl With Anti-myelin Oligodendrocyte Glycoprotein Antibody Seropositive Optic Neuritis"],"prefix":"10.7759","author":[{"given":"Midori","family":"Tachibana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo A","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, et al.. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018, 90:e1858-69. 10.1212\/WNL.0000000000005560","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016, 13:280. 10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02160-9","article-title":"Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?","volume":"18","author":"Havla J","year":"2021","unstructured":"Havla J, Pakeerathan T, Schwake C, et al.. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?. J Neuroinflammation. 2021, 18:121. 10.1186\/s12974-021-02160-9","journal-title":"J Neuroinflammation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25909","article-title":"Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"89","author":"Cobo-Calvo A","year":"2021","unstructured":"Cobo-Calvo A, Ruiz A, Rollot F, et al.. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 2021, 89:30-41. 10.1002\/ana.25909","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01339","article-title":"Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody","volume":"10","author":"Takano S","year":"2019","unstructured":"Takano S, Hanabusa A, Yoshikawa Y, et al.. Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody. Front Neurol. 2019, 10:1339. 10.3389\/fneur.2019.01339","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters P","year":"2020","unstructured":"Waters P, Fadda G, Woodhall M, et al.. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 2020, 77:82-93. 10.1001\/jamaneurol.2019.2940","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2023.12.006","article-title":"Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"48","author":"Gericke FC","year":"2024","unstructured":"Gericke FC, Hanson JV, Hackenberg A, Gerth-Kahlert C. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Eur J Paediatr Neurol. 2024, 48:113-20. 10.1016\/j.ejpn.2023.12.006","journal-title":"Eur J Paediatr Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26440","article-title":"Longitudinal retinal changes in MOGAD","volume":"92","author":"Oertel FC","year":"2022","unstructured":"Oertel FC, Sotirchos ES, Zimmermann HG, et al.. Longitudinal retinal changes in MOGAD. Ann Neurol. 2022, 92:476-85. 10.1002\/ana.26440","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11256-y","article-title":"Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode","volume":"269","author":"Pakeerathan T","year":"2022","unstructured":"Pakeerathan T, Havla J, Schwake C, et al.. Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode. J Neurol. 2022, 269:6366-76. 10.1007\/s00415-022-11256-y","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120269","article-title":"Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD","volume":"437","author":"Akaishi T","year":"2022","unstructured":"Akaishi T, Himori N, Takeshita T, et al.. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD. J Neurol Sci. 2022, 437:120269. 10.1016\/j.jns.2022.120269","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012125","article-title":"APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies","volume":"97","author":"Aytulun A","year":"2021","unstructured":"Aytulun A, Cruz-Herranz A, Aktas O, et al.. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021, 97:68-79. 10.1212\/WNL.0000000000012125","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-016-9553-y","article-title":"ISCEV standard for clinical visual evoked potentials: (2016 update)","volume":"133","author":"Odom JV","year":"2016","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016, 133:1-9. 10.1007\/s10633-016-9553-y","journal-title":"Doc Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46251-3","article-title":"In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis","volume":"9","author":"Vabanesi M","year":"2019","unstructured":"Vabanesi M, Pisa M, Guerrieri S, et al.. In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis. Sci Rep. 2019, 9:10371. 10.1038\/s41598-019-46251-3","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.02.371","article-title":"Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients","volume":"281","author":"Watanabe A","year":"2009","unstructured":"Watanabe A, Matsushita T, Doi H, et al.. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. J Neurol Sci. 2009, 281:34-40. 10.1016\/j.jns.2009.02.371","journal-title":"J Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier R","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, et al.. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021, 20:762-72. 10.1016\/S1474-4422(21)00218-0","journal-title":"Lancet Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.03.014","article-title":"Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: a cohort study in China","volume":"400","author":"Song H","year":"2019","unstructured":"Song H, Zhou H, Yang M, Xu Q, Sun M, Wei S. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: a cohort study in China. J Neurol Sci. 2019, 400:83-9. 10.1016\/j.jns.2019.03.014","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/srep04687","article-title":"Immature visual neural system in children reflected by contrast sensitivity with adaptive optics correction","volume":"4","author":"Liu R","year":"2014","unstructured":"Liu R, Zhou J, Zhao H, Dai Y, Zhang Y, Tang Y, Zhou Y. Immature visual neural system in children reflected by contrast sensitivity with adaptive optics correction. Sci Rep. 2014, 4:4687. 10.1038\/srep04687","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21823","article-title":"Neuroplasticity predicts outcome of optic neuritis independent of tissue damage","volume":"67","author":"Jenkins TM","year":"2010","unstructured":"Jenkins TM, Toosy AT, Ciccarelli O, et al.. Neuroplasticity predicts outcome of optic neuritis independent of tissue damage. Ann Neurol. 2010, 67:99-113. 10.1002\/ana.21823","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508091367","article-title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography","volume":"14","author":"Costello F","year":"2008","unstructured":"Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler. 2008, 14:893-905. 10.1177\/1352458508091367","journal-title":"Mult Scler"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18736","article-title":"Retinal ganglion cell layer thinning within one month of presentation for non-arteritic anterior ischemic optic neuropathy","volume":"57","author":"Kupersmith MJ","year":"2016","unstructured":"Kupersmith MJ, Garvin MK, Wang JK, Durbin M, Kardon R. Retinal ganglion cell layer thinning within one month of presentation for non-arteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2016, 57:3588-93. 10.1167\/iovs.15-18736","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255586-pattern-visually-evoked-potentials-pveps-and-retinal-nerve-fiber-thickness-in-a-japanese-girl-with-anti-myelin-oligodendrocyte-glycoprotein-antibody-seropositive-optic-neuritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T10:50:41Z","timestamp":1721818241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255586-pattern-visually-evoked-potentials-pveps-and-retinal-nerve-fiber-thickness-in-a-japanese-girl-with-anti-myelin-oligodendrocyte-glycoprotein-antibody-seropositive-optic-neuritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.65254","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}